Carmel Capital Partners’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.95M Sell
6,230
-130
-2% -$65.4K 1.06% 27
2025
Q4
$2.97M Buy
6,360
+2,017
+46% +$936K 1.04% 28
2025
Q3
$1.85M Sell
4,343
-1,313
-23% -$509K 0.78% 30
2025
Q2
$2.17M Buy
5,656
+564
+11% +$203K 0.76% 35
2025
Q1
$1.76M Sell
5,092
-183
-3% -$58.9K 0.69% 32
2024
Q4
$1.58M Buy
5,275
+808
+18% +$282K 0.64% 32
2024
Q3
$1.82M Sell
4,467
-433
-9% -$159K 0.7% 26
2024
Q2
$1.57M Buy
4,900
+20
+0.4% +$6.5K 0.66% 27
2024
Q1
$1.63M Buy
+4,880
New +$1.49M 0.67% 29
2023
Q4
Sell
-15
Closed -$3.69K 379
2023
Q3
$3.69K Buy
+15
New +$4.11K ﹤0.01% 581

Other funds holding HCA

Carmel Capital Partners's HCA Position: Q1 2026 in Review

Carmel Capital Partners reduced its HCA Healthcare (HCA) stake by 2% in Q1 2026, selling an estimated $65.4K and leaving 6,230 shares worth $2.95M. The position accounts for 1.06% of the portfolio, ranked #27.

Carmel Capital Partners first reported a position in HCA in Q3 2023 and has held it in 10 quarters since. The position peaked at $2.97M in Q4 2025. 1,414 funds tracked by Wall St. Rank hold HCA as of Q1 2026.

  • Carmel Capital Partners held 6,230 shares of HCA Healthcare worth $2.95M as of Q1 2026.
  • Carmel Capital Partners sold 130 HCA Healthcare shares in Q1 2026, an estimated $65.4K.
  • HCA Healthcare made up 1.06% of Carmel Capital Partners's portfolio in Q1 2026, its #27 holding.
  • Carmel Capital Partners first reported a position in HCA Healthcare in Q3 2023 and has held it in 10 quarters since.
  • Carmel Capital Partners's HCA Healthcare position peaked at $2.97M in Q4 2025.
  • 1,414 funds tracked by Wall St. Rank held HCA Healthcare as of Q1 2026.

Based on Carmel Capital Partners's 13F filing for Q1 2026, filed 30 Apr 2026.